---
schema_version: "secwatch.filing_event.v1"
accession: "0001867096-25-000031"
form_type: "8-K"
ticker: "XERS"
cik: "0001867096"
company_name: "Xeris Biopharma Holdings, Inc."
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T06:25:49.941532+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Xeris appoints Dr. Anh Nguyen as CMO; Ken Johnson retiring April 1, 2025

## Summary
- Dr. Anh Nguyen named Chief Medical Officer effective Feb 24, 2025.
- Ken Johnson, SVP Global Dev & Medical Affairs, to retire April 1, 2025.
- Nguyen will lead Medical, Regulatory, Preclinical/Clinical Dev, Pharmacovigilance.
- Nguyen previously served as program medical lead for Gvoke NDA/MAA at Xeris.

## SEC filing metadata
- accession: 0001867096-25-000031
- form_type: 8-K
- ticker: XERS
- cik: 0001867096
- company_name: Xeris Biopharma Holdings, Inc.
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867096/000186709625000031/0001867096-25-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867096/000186709625000031/xers-20250224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001867096-25-000031
- JSON: https://secwatch.observer/filing/0001867096-25-000031.json
- Plain text: https://secwatch.observer/filing/0001867096-25-000031.txt

## Key facts
- Executive change
  Ken Johnson retired as Senior Vice President, Global Development and Medical Affairs at Xeris Biopharma Holdings, Inc..
  - Action: retired
  - Role: Senior Vice President, Global Development and Medical Affairs
  source text: On February 24, 2025, Mr. Ken Johnson, Pharm.D. notified Xeris Biopharma Holdings, Inc. (the “Company”) of his decision to retire as Senior Vice President, Global Development and Medical Affairs, effective as of April 1, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1867096/000186709625000031/0001867096-25-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.